President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

List includes medications for diabetes, cancer, arthritis, and more ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Medicare picks Botox and Trulicity for latest round of negotiations The Centers for ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

Fifteen prescription medications will be the focus of federal price negotiations that could lower prices for Medicare patients.

CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

Medicare Part D and some Medicare Advantage (Part C) plans may cover Trulicity for managing type 2 diabetes, but coverage specifics depend on the plan’s formulary (drug list). Medicare typically does ...